DoMore Diagnostics And Proscia Partner To Inform Personalized Treatment Decisions For Colorectal Cancer Patients
Collaboration holds the promise to reduce overtreatment with integrated AI-powered pathology workflows OSLO and PHILADELPHIA, Aug. 30, 2023 /PRNewswire-PRWeb/ -- DoMore Diagnostics, a leader in deep learning precision diagnostics for digital pathology, and Proscia®, a leading provider of...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Information Technology | Learning | Pathology | Pharmaceuticals | Universities & Medical Training